Explore how aggressive breast cancer evades immune defences and discover potential treatment strategies with our latest ...

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind ...

A phase II trial of neoadjuvant docetaxel/5-FU/cisplatin in combination with prophylactic pegteograstim in unresectable, locally advanced nasal cavity/paranasal squamous cell carcinoma: KCSG HN18-07.

This review highlights how natural polysaccharide-based microneedles (PMNs) are emerging as a transformative platform for cancer immunotherapy. We report their unique dual role in drug delivery and ...

“PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility,” by Astellas Pharma Inc. News release; Dec. 17, 2025.

Cancer immunotherapy involves harnessing the body's immune system to fight tumors; however, delivering treatments effectively and precisely remains a ...

This illustration summarizes how integrated spatial transcriptomics, single-cell transcriptomics, single-cell epigenomics, and spatial epigenomics enable multi-dimensional profiling of the tumor ...

Immunotherapy is a type of cancer treatment. Some forms of this treatment may help treat bone cancer. However, experts need to conduct more research into immunotherapy for primary bone cancer. Primary ...